BioMar Updates Full-Year Guidance
BioMar released an announcement with updated full-year guidance.
Related stories
Anthropic IPO set to define AI trade
Anthropic’s $1.4 trillion IPO on Thursday sets up a defining test for an AI trade buffeted by market turbulence, mounting political backlash, and a crisis at Nvidia. Now roughly si
H impact | EARNINGS | Nov 15, 2026, 10:36 PM UTC
Maire Expects LNG Licensing Business to Generate at Least $25 Million EBITDA in 2027
Maire expects its acquired LNG licensing business to generate at least USD 25 million in EBITDA in 2027.
M impact | EARNINGS | Nov 15, 2026, 06:58 PM UTC
StubHub Raises Full-Year Gross Merchandise Sales Outlook to $10.3 Billion
StubHub raised its full-year gross merchandise sales outlook to $10.3 billion from $10.1 billion.
M impact | EARNINGS | Nov 15, 2026, 02:03 AM UTC
Merlin Properties Raises 2026 FFO Guidance to EUR 0.58 per Share
Merlin Properties raised its 2026 FFO guidance to EUR 0.58 per share and updated its strategy for its 704 MW data center portfolio.
M impact | EARNINGS | Nov 14, 2026, 08:03 PM UTC
Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million
Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond raised
L impact | EARNINGS | Nov 14, 2026, 01:10 AM UTC
Gilead Expects HIV Revenue to Grow About 12% in 2026
Gilead expects HIV revenue to grow about 12% in fiscal 2026.
M impact | EARNINGS | Nov 14, 2026, 12:44 AM UTC